Literature DB >> 7651277

Pathology of adrenal neoplasms.

W Saeger1.   

Abstract

The use of immunohistochemistry and electron microscopy enables the strict separation of adreno-cortical and adreno-medullary tumors in every case, as tumors of the medulla are generally positive for neuroendocrine markers (chromogranin A, synaptophysin) and negative for D11 whereas those of the cortex are stained with D11 and are negative with the other markers. Our surgical collection of cortical tumors and tumor-like lesions (n = 104) covers adenomas (39%), carcinomas (15%), microadenomatosis (2%), macronodular hyperplasia (4%), hemangioma (1%), myelolipoma (2%), hematoma (1%), pseudocysts (2%), and metastases (6%). The often difficult interpretation of dignity was aided by a point system of criteria. Isolated nodules were differentiated from adenomas by their size (ie less than 3 cm), the histological pattern and the lack of cellular atypia. Correlations of the lesions with the endocrine functions were presented. The tumors of the medulla (n = 42) were differentiated in pheochromocytomas (88%), malignant pheochromocytomas (7%), neuroblastomas (2%), and ganglioneuroblastomas (2%). 8-10% of pheochromocytomas are malignant, but with the exception of invasion of the capsule or of the veins or the demonstration of metastases, no other reliable criteria for malignancy exist. The lack of S100-protein-immunoreacting satellite cells may indicate a malignant growth. 89% of pheochromocytomas in our collection were shown to be endocrine active secreting catecholamines and in one case additionally ACTH.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651277

Source DB:  PubMed          Journal:  Minerva Endocrinol        ISSN: 0391-1977            Impact factor:   2.184


  5 in total

Review 1.  Adrenal myelolipomas.

Authors:  Jan Calissendorff; Carl Christofer Juhlin; Anders Sundin; Irina Bancos; Henrik Falhammar
Journal:  Lancet Diabetes Endocrinol       Date:  2021-08-24       Impact factor: 32.069

2.  N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma.

Authors:  Amir Khorram-Manesh; Håkan Ahlman; Svante Jansson; Ola Nilsson
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 3.  [Adrenocortical tumours].

Authors:  W Saeger
Journal:  Pathologe       Date:  2003-05-06       Impact factor: 1.011

4.  Predictors of malignancy in primary aldosteronism.

Authors:  Ayman Agha; Matthias Hornung; Igors Iesalnieks; Andreas Schreyer; Ernst Michael Jung; Assad Haneya; Hans J Schlitt
Journal:  Langenbecks Arch Surg       Date:  2013-09-19       Impact factor: 3.445

5.  Spontaneous rupture of adrenal haemangioma mimicking abdominal aortic aneurysm rupture.

Authors:  Piotr Paluszkiewicz; Iwona Ambroziak; Katarzyna Hołyńska-Dąbrowska; Zofia Siezieniewska-Skowrońska; Andrzej Paluszkiewicz
Journal:  Arch Med Sci       Date:  2010-03-09       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.